PCM Encore »

Ultragenyx Pharmaceutical shares owned by PCM Encore

Quarter-by-quarter ownership of Ultragenyx Pharmaceutical (RARE) shares owned by PCM Encore from 13F filings

Historical chart of PCM Encore investment in Ultragenyx Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Ultragenyx Pharmaceutical held by PCM Encore consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ultragenyx Pharmaceutical by PCM Encore

Quarter filed Position value Share count Share price at filing
2026-06-30 $211k 6.3k 33.39

More positions owned by PCM Encore

NVIDIA Corporation (NVDA)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Russell 2000 Etf (IWM)
Amazon (AMZN)
Broadcom (AVGO)
Eli Lilly & Co. (LLY)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Core Msci Emkt (IEMG)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Micron Technology (MU)

View all positions for PCM Encore

Top funds holding Ultragenyx Pharmaceutical

BlackRock
Rtw Investments
Vanguard Portfolio Management
AQR Capital Management
State Street Corporation
Vanguard Capital Management
Two Sigma Investments
Sands Capital Management
Jacobs Levy Equity Management
Frontier Capital Management
Geode Capital Management
Sofinnova Ventures
Bellevue Group
D. E. Shaw & Co
Adage Capital Partners GP

View all funds holding Ultragenyx Pharmaceutical